NOW is the Time for Hepatitis C Virus Elimination

By Ana Balkandjieva

23 January 2024

HCV high-burden populations
Viral hepatitis elimination

Hepatitis C-related liver diseases continue to kill an estimated 15,000 people per year in the United States, despite the availability of an effective cure.

Treatment Action Group (TAG) released a publication that makes the case for prioritizing hepatitis C virus (HCV) elimination domestically, in keeping with the Viral Hepatitis National Strategic Plan: 2021 – 2025. It outlines pertinent barriers to HCV care among key populations, as well as action steps for proactively addressing them to diagnose and treat more people living with HCV.

Download the publication below.

* Image source: https://www.cdc.gov/vitalsigns/hepc-treatment/index.html

Attached documents

NOW is the Time for Hepatitis C Virus Elimination

PDF – 1.1 MiB

Related materials

Eliminating Hepatitis C in Europe: Report on Policy Implementation for People Who Inject Drugs

C-EHRN releases a report focusing on the availability of and access to interventions that constitute the HCV continuum of care specific for people who inject drugs in 35 European cities. More

6 February 2024Advocate Advocacy Tools

Charting a New Course to Hepatitis Elimination in Pakistan

The dire need is to make hepatitis elimination a national priority with a strategic shift in governance and policy and ensuring the intelligent expenditure of resources. More

10 February 2024Advocate Policy Statements

ACHIEVE Call to Action for the New EU Legislature 2024-2029

ACHIEVE issues a call to action outlining actions different actors (Member States, Stakeholders, European Commission and European Parliament) can take to eliminate viral hepatitis B and C in the European Union/European Economic Area. More

10 February 2024Advocate Policy Statements

Progress Towards Elimination of Viral Hepatitis: a Lancet Gastroenterology & Hepatology Commission Update

The Commission update focuses on national progress among the 20 countries most heavily burdened with viral hepatitis (75% of the global burden). An effective response in these countries is crucial if global elimination targets are to be achieved. More

25 February 2024News Partner News

Development and Optimisation of a Reception Testing Protocol Designed to Eliminate HCV in the UK Prison Population

A study shows that an opt-out HCV test and treat initiative in prison receptions is feasible and can be adapted to the needs of individual prisons as a viable way to achieve HCV micro-elimination. More

16 March 2024Learn Diagnostics

2024 Global Hepatitis Report

WHO sounds alarm on viral hepatitis infections claiming 3500 lives each day. Viral hepatitis is the second leading infectious cause of death globally. More

11 April 2024Advocate Advocacy Tools

ECDC: High Burden of Hepatitis B and C Persists in the EU/EEA

Recent ECDC data show that despite progress in prevention and control efforts, hepatitis B and C continue to pose significant public health challenges in the European Union and European Economic Area. More

19 May 2024News Partner News

Implementing the Global Health Sector Strategies on HIV, Viral Hepatitis and STIs, 2022–2030: WHO Report on Progress and Gaps 2024

New WHO report flags major increase in sexually transmitted infections, amidst challenges in HIV and hepatitis. More

22 May 2024Advocate Advocacy Tools

Global Hepatitis Webinar – It’s Time for Action!

To mark World Hepatitis Day 2024, WHO will host a global webinar to highlight the need for the global health community to get back on track toward viral hepatitis elimination by 2030. More

14 July 2024News Calendar

Community-Based HCV Self-Testing Widens Testing Access in Big Vietnam Study

Community-based HCV self-testing could broaden access to testing by reaching previously untested people, could boost new HCV diagnoses and expand linkage to HCV care. More

10 August 2024Learn Diagnostics